返回ChemicalBook首页>CAS数据库列表>24003-58-5

24003-58-5

中文名称 N-ETHYLLIDOCAINE BROMIDE
英文名称 N-ETHYLLIDOCAINE BROMIDE
CAS 24003-58-5
分子式 C16H27N2OBr
分子量 343.31
MOL 文件 24003-58-5.mol
更新日期 2024/05/06 18:29:27
24003-58-5 结构式 24003-58-5 结构式

基本信息

中文别名
化合物 T16707
英文别名
N-ETHYLLIDOCAINE BROMIDE
[2-(2,6-dimethylanilino)-2-oxoethyl]-triethylazanium:bromide
2-[(2,6-DIMETHYLPHENYL)AMINO]-N,N,N-TRIETHYL-2-OXO-ETHANAMINIUM BROMIDE

物理化学性质

储存条件Desiccate at RT
溶解度insoluble in EtOH; ≥10.5 mg/mL in H2O; ≥25.55 mg/mL in DMSO
形态结晶固体
颜色白色
水溶解性溶于水至100mM

常见问题列表

生物活性
QX-314 bromide 是一种膜不渗透的钠离子通道永久性电荷阻滞剂。
靶点

sodium channel

体外研究

QX-314 bromide exerts biphasic effects on transient receptor potential vanilloid subtype 1 channels (TRPV1) in vitro .
QX-314 bromide (1–60 mM) directly activates TRPV1 in a concentration-dependent manner.
QX-314 bromide (≥ 30 mM) produces oocyte membrane blackening and cell death .
QX-314 bromide inhibits calcium currents in hippocampal CA1 pyramidal neurons intracellular, and the low-threshold (T-type) Ca 2+ currents are on average < 10% of control amplitude .
QX-314 bromide shifts the current-voltage relationships (I-Vs) in the positive voltage direction due to the presence of intracellular Br- .

体内研究

QX-314 bromide (1.6 mg/kg; i.c.) abolishes responses to noxious mechanical and thermal stimuli without motor or tactile deficits when co-treatment with capsaicin.

Animal Model: Male Sprague-Dawley rats (250-290 g)
Dosage: 1.6 mg/kg
Administration: Intracutaneous injection
Result: Abolished responses to noxious mechanical and thermal stimuli without motor or tactile deficits when co-treatment with capsaicin.
"24003-58-5" 相关产品信息